封面
市場調查報告書
商品編碼
1924724

按產品類型、手術類型、材質類型、病患年齡層、最終用途和分銷管道分類的卵圓孔未閉封堵器市場—2026-2032年全球預測

PFO Closure Device Market by Product Type, Procedure Type, Material Type, Patient Age Group, End Use, Distribution Channel - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年,PFO 封堵器市值將達到 2.9555 億美元,到 2026 年將成長至 3.3671 億美元,到 2032 年將達到 7.8287 億美元,複合年成長率為 14.93%。

關鍵市場統計數據
基準年 2025 2.9555億美元
預計年份:2026年 3.3671億美元
預測年份 2032 7.8287億美元
複合年成長率 (%) 14.93%

本文全面概述了影響卵圓孔未閉封堵器應用的臨床、監管和營運因素,以及相關人員如何權衡療效和易用性。

圍繞卵圓孔封堵器的臨床和商業性爭論已演變為一場多學科對話,旨在平衡手術有效性、器械設計以及與醫療保健系統的整合。臨床醫生、器械製造商、醫院管理者和支付方共用找到能夠最大限度減少手術複雜性和住院時間,同時降低特定患者群體卒中復發風險的解決方案。因此,推動創新的不僅是封堵器的設計和輸送機制,還包括手術流程最佳化、影像互通性與現有導管檢查室和混合手術室基礎設施的兼容性。

器械材料、輸送自動化、臨床證據產生和價值主導採購等方面的同步進步,正在重新定義卵圓孔未閉(PFO)封堵術的競爭優勢。

卵圓孔未閉(PFO)封堵技術領域正在發生重大變革,重塑產業格局。這些變革反映了器械材料和輸送機制的進步,以及不斷累積的實證醫學證據對病人選擇的最佳化。製造商正在將鎳鈦合金支架與聚合物密封元件結合,以提高封堵器的貼合性並降低器械相關的血栓形成風險。同時,輸送系統也朝著更自動化和可控的方向發展,以減少操作者差異。這些技術趨勢也伴隨著手術流程的創新,經導管介入治療在許多情況下正逐漸取代創傷性更大的外科手術,從而縮短患者的恢復時間並減少醫院資源的消耗。

關稅調整與跨境貿易摩擦對PFO封堵器產業供應鏈在地化、策略性製造地轉移與定價策略的影響

關稅政策和跨境貿易趨勢對卵圓孔未閉封堵器生態系統有直接和間接的影響,包括採購決策、生產在地化和經銷商的經濟效益。醫療設備組件關稅的提高將增加依賴特種合金、聚合物和精密製造流程的系統到岸成本,促使製造商重新評估其全球供應鏈,並考慮關鍵組件的在地化生產。這種轉變可能導致資本重新配置,用於在低關稅地區或近岸地區建立或擴大生產能力,以維持對醫院和門診病人客戶的價格競爭力。

按產品類型、手術途徑、材料、通路和患者群體分類的細分洞察,重點關注不同的臨床需求、採購趨勢和商業化促進因素

從細緻的市場區隔觀點來看,產品類型、手術流程、最終用戶、材料、分銷管道和患者群體等因素都會影響市場需求和產品應用路徑。依產品類型檢驗,市場由配件、輸送系統和封堵器組成。配件可細分為導管導引線、鞘套和穩定套管組件。輸送系統分為自動輸送和手動輸送兩種類型,封堵器則分為雙盤式和單盤式兩種結構。依手術流程分類,主要有兩種手術途徑:外科手術和經導管封堵。外科手術包括微創手術和開放性手術,經導管封堵則透過股靜脈或頸靜脈入路進行。依最終使用者分類,門診手術中心和醫院是兩種不同的應用環境,二者的手術量、人員配備模式和設備限制各不相同。

臨床實務、管理體制和支付模式的地理差異如何導致全球主要地區卵圓孔未閉封堵器採用路徑的差異

區域特徵對臨床實務模式、監管預期和商業策略有顯著影響,不同地理區域在手術技術偏好、支付方環境和基礎設施能力方面各有特色。美洲地區集中了許多大型醫院網路和成熟的介入性心臟病學項目,這為循證經導管解決方案和廣泛的上市後數據收集提供了支持。該地區的採購週期通常需要強力的臨床和經濟價值提案,而報銷途徑也會對產品採用率產生重大影響。在歐洲、中東和非洲,不同的法規結構和不斷變化的醫療保健系統資金籌措模式為彈性價格設定和社區培訓計劃創造了機會。然而,該地區的部分市場更傾向於偏好能夠在資源有限的環境中部署並適應不同手術方式的器械。

策略性企業行動和競爭定位凸顯了整合的產品系列、證據產生和經銷夥伴將如何決定卵圓孔未閉封堵裝置的市場滲透率。

PFO封堵器市場的主要企業正採取不同的策略,以反映各自的技術優勢、臨床試驗投入和商業性佈局。成熟的器械製造商利用整合的產品組合,將封堵器與配套的輸送系統和輔助組件結合,打造捆綁式解決方案,從而簡化採購流程和臨床醫生培訓。這些公司通常會投資大規模註冊研究和研究者主導試驗,以建立支付方和醫療系統所需的循證依據,同時還開展全面的臨床醫生教育和指導項目,以加速在高流量中心推廣應用。

產業領導者可以採取切實有效、影響深遠的措施,以加速卵圓孔未閉封堵裝置的普及和商業性成功(透過協調產品、臨床和市場推廣策略)。

致力於擴大卵圓孔未閉(PFO)封堵解決方案臨床應用並提升商業性效益的行業領導者應採取多管齊下的策略,整合工程設計、循證實踐和產品上市流程。首先,他們應投資於產品研發,在確保機械可靠性的同時兼顧易用性,優先選擇能夠降低手術操作差異和併發症發生率的材料和輸送機制。其次,他們應制定嚴謹的實證藍圖,包括前瞻性註冊研究和實用性臨床試驗,以檢驗不同臨床環境下的治療效果,並滿足支付方和醫院的決策標準。第三,他們應設計臨床醫生教育和指導項目,整合模擬訓練和現場支持,以縮短學習曲線並鞏固最佳實踐。

採用嚴謹的多面向調查方法,整合臨床醫師訪談、設備技術評估、監管審查和商業通路分析,以得出可靠的見解。

本分析整合了專家訪談、醫療設備技術規範、監管文件、臨床文獻和公共趨勢,全面展現了卵圓孔未閉(PFO)封堵器材市場​​。主要研究包括對介入性心臟病專家、電生理學家、醫院採購人員和分銷合作夥伴進行結構化訪談,以收集有關器械選擇、手術流程和服務預期等方面的實際考慮。次要資訊來源包括同行評審的臨床研究、器械標籤和說明書以及已發布的監管決策,以確保器械宣稱的性能與實際應用相符。

對臨床、商業性和監管要求的簡要總結,突顯了決定哪些卵圓孔未閉封堵方案能夠獲得持續應用和基於價值的認可的關鍵因素。

總之,卵圓孔未閉封堵器市場呈現出融合的動態特徵:材料和輸送技術的創新、對可操作臨床動態的需求,以及必須同時滿足大型醫院系統和不斷擴展的門診服務的商業模式。製造商和相關人員的成功取決於其能否提供可證實的臨床價值、簡化手術流程,並根據不同的終端使用者環境調整分銷和定價策略。關稅、區域監管環境以及不斷變化的支付方期望等因素的相互作用,進一步凸顯了建立適應性供應鏈和製定有針對性的市場推廣計劃的必要性。

目錄

第1章:序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

8. 依產品類型分類的卵圓孔未閉封堵器市場

  • 配件
    • 導管導引線
    • 鞘套
    • 穩定套
  • 配送系統
    • 自動交付機制
    • 手動交付機制
  • 閉合裝置
    • 雙碟裝
    • 單碟裝

9. 依手術類型分類的卵圓孔未閉封堵器市場

  • 手術縫合
    • 微創
    • 開放性手術
  • 經導管閉合術
    • 股靜脈通路
    • 頸靜脈通路

第10章 依材料類型分類的卵圓孔未閉封堵器市場

  • 鎳鈦諾
  • 聚合物
    • 聚酯纖維
    • 乙胺類藥物

11. 依患者年齡層分類的卵圓孔未閉封堵器市場

  • 成人版
  • 兒童

12. 依最終用途分類的卵圓孔未閉封堵器市場

  • 門診手術中心
  • 醫院

13. 依通路分類的卵圓孔未閉封堵器市場

  • 線上
  • 離線

14. 依地區分類的卵圓孔未閉封堵器市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 依組別分類的卵圓孔未閉封堵器市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國卵圓孔未閉封堵器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國卵圓孔未閉封堵器市場

第18章:中國卵圓孔未閉封堵器市場

第19章 競爭情勢

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年
  • Abbott Laboratories
  • Artech Medical, Inc.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardia, Inc.
  • Cardiovascular Systems, Inc.
  • Coherex Medical, Inc.
  • Lepu Medical Technology(Beijing)Co., Ltd.
  • Lifetech Scientific(Shenzhen)Co., Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Neovasc Inc.
  • Occlutech International AG
  • pfm medical ag
  • Sahajanand Medical Technologies Limited
  • Starway Medical Technology, Inc.
  • Surmodics, Inc.
  • Vascular Innovations Co., Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-7A380DA7C455

The PFO Closure Device Market was valued at USD 295.55 million in 2025 and is projected to grow to USD 336.71 million in 2026, with a CAGR of 14.93%, reaching USD 782.87 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 295.55 million
Estimated Year [2026] USD 336.71 million
Forecast Year [2032] USD 782.87 million
CAGR (%) 14.93%

A compelling overview of the clinical, regulatory, and operational forces shaping adoption of PFO closure devices and how stakeholders prioritize outcomes and usability

The clinical and commercial narrative around patent foramen ovale closure devices has evolved into a multidisciplinary dialogue that balances procedural efficacy, device design, and health-system integration. Clinicians, device manufacturers, hospital administrators, and payers converge around a demand for solutions that demonstrably reduce stroke recurrence in selected patient cohorts while minimizing procedural complexity and length of stay. As a result, innovation is driven not only by occluder design and delivery mechanics but also by procedural workflow optimization, imaging interoperability, and compatibility with existing cath lab or hybrid operating room infrastructure.

From a regulatory and reimbursement perspective, stakeholders increasingly expect robust real-world data and longitudinal follow-up to substantiate comparative effectiveness claims. This environment favors devices and accessory systems that enable reproducible deployment, reduce periprocedural complications, and support consistent patient selection criteria. Meanwhile, manufacturers face commercial pressures to provide comprehensive training and support for adoption across ambulatory surgical centers and hospital settings. Taken together, these dynamics set the context for the rest of this analysis: a market where clinical outcomes, ease of use, and ecosystem support determine differentiation and where strategic decisions must bridge clinical evidence and pragmatic adoption barriers.

How simultaneous advances in device materials, delivery automation, clinical evidence generation, and value-driven procurement are redefining competitive advantage in PFO closure

Significant transformative shifts are reshaping the landscape for PFO closure technologies, reflecting advances in device materials, delivery mechanics, and an expanding evidence base that refines patient selection. Manufacturers are integrating nitinol-based frameworks with polymeric sealing elements to improve conformability and reduce device-related thrombogenicity, while delivery systems are evolving toward more automated and controlled deployment mechanisms to lower operator variability. These engineering trends are accompanied by procedural innovations; transcatheter approaches continue to supplant more invasive surgical techniques in many settings, driven by shorter recovery times and reduced hospital resource utilization.

Concurrently, payer expectations and hospital procurement strategies are aligning around value-based outcomes. Hospital systems and ambulatory surgical centers increasingly require demonstration of cost-effectiveness alongside clinical benefit, which has prompted device developers to invest in robust registries and post-market surveillance to capture real-world performance. Market entry strategies now emphasize bundled care pathways and clinician training programs to accelerate adoption. Finally, supply chain resilience and regulatory harmonization across regions are influencing product design and manufacturing footprints, prompting strategic partnerships and localized distribution arrangements that can shorten time to market and adapt to regional procedural preferences.

How evolving tariff regimes and cross-border trade frictions are driving supply chain localization, strategic manufacturing shifts, and pricing strategies in the PFO closure device sector

Tariff policy and cross-border trade dynamics have immediate and downstream effects on the PFO closure device ecosystem, influencing sourcing decisions, manufacturing localization, and distributor economics. Increased tariffs on medical device components can raise the landed cost of systems that rely on specialized alloys, polymers, or precision manufacturing, incentivizing manufacturers to reassess global supply chains and consider regional production for critical components. This shift can result in reallocation of capital toward establishing or expanding manufacturing capabilities in lower-tariff jurisdictions or nearshore locations to maintain price competitiveness for hospital and ambulatory customers.

Beyond direct cost implications, tariffs can alter strategic partnerships between original equipment manufacturers and contract manufacturers, prompting renegotiation of supplier contracts and lead times. For device developers pursuing evidence generation and clinical trials across borders, changes in import/export costs for trial devices and ancillary components may affect trial timelines and budgeting. Distributors facing margin compression may adjust stocking strategies or revise service offerings to preserve economics. Collectively, these tariff-driven pressures accelerate strategic decisions around localization, pricing models, and channel structuring, with implications for how quickly new device iterations reach clinicians and patients.

Segment-specific insights that expose distinct clinical requirements, procurement preferences, and commercialization levers across product types, procedural pathways, materials, channels, and patient cohorts

A nuanced segmentation lens reveals differentiated demand drivers and adoption pathways across product types, procedures, end users, materials, distribution channels, and patient populations. Examining product type, the market encompasses Accessories, Delivery Systems, and Occluders, with Accessories further differentiated into guidewire, sheath, and stabilization sleeve components, delivery systems subdivided between automated delivery mechanisms and manual delivery mechanisms, and occluders characterized by double disc and single disc architectures. Procedure type segmentation shows two primary procedural channels: surgical closure and transcatheter closure, where surgical approaches include minimally invasive and open surgery variants while transcatheter techniques are performed via femoral vein access or jugular vein access. End use differentiation identifies ambulatory surgical centers versus hospitals as distinct adoption environments with different procedural volumes, staffing models, and capital equipment constraints.

Material-type considerations are central to device performance and manufacturing complexity; devices built from nitinol provide favorable mechanical memory and conformability, whereas polymer-based options, including Dacron and expanded polytetrafluoroethylene, offer alternative sealing strategies and tissue integration profiles. Distribution channel structures influence market reach and service expectations, with direct sales models often paired with high-touch training and clinical support, while distributor-led approaches operate through offline and online channels to extend geographical footprint. Patient age group segmentation between adult and pediatric cohorts imposes divergent design and regulatory constraints, as pediatric applications demand miniaturization and long-term biocompatibility data. Understanding these intersecting segments is essential for product positioning, clinical trial design, and commercial rollout plans.

How geographic differences in clinical practice, regulatory regimes, and payer models create differentiated pathways to adoption for PFO closure devices across major global regions

Regional dynamics shape clinical practice patterns, regulatory expectations, and commercial strategies in meaningful ways, with different geographies exhibiting unique procedural preferences, payer landscapes, and infrastructure capacities. In the Americas, there is a concentration of large hospital networks and established interventional cardiology programs that favor evidence-backed transcatheter solutions and support extensive post-market data collection. Procurement cycles in this region often demand robust clinical and economic value propositions, and reimbursement pathways can materially influence adoption speed. In Europe, Middle East & Africa, heterogeneous regulatory frameworks and variable health-system funding models create opportunities for flexible pricing and localized training initiatives, while some markets within the region place a premium on devices that can be deployed in lower-resource settings or adapted to different procedural access preferences.

Asia-Pacific presents a mix of high-volume tertiary centers in some markets and rapidly expanding ambulatory care capacity in others, leading manufacturers to tailor market entry strategies between flagship partnerships with leading cardiac centers and broader distributor networks. This region also shows increasing interest in local manufacturing and regulatory harmonization, which can accelerate product approvals and lower import-related cost pressures. Across regions, the common threads are an emphasis on demonstrable clinical outcomes, adaptability of delivery systems to local practice patterns, and the need to align commercial models with prevailing hospital and outpatient care economics.

Strategic company behaviors and competitive positioning that highlight how integrated portfolios, evidence generation, and distribution partnerships determine market traction for PFO closure devices

Key companies operating in the PFO closure device landscape pursue varied strategies that reflect their technological strengths, clinical trial investments, and commercial footprints. Established device manufacturers often leverage integrated portfolios that combine occluders with complementary delivery systems and accessory components, enabling bundled offerings that simplify procurement and clinician training. These companies typically invest in large-scale registries and investigator-initiated studies to build the evidence base required by payers and health systems, while also deploying comprehensive clinician education and proctoring programs to accelerate adoption across high-volume centers.

Emerging and niche players frequently focus on differentiated materials or novel deployment mechanisms to carve out clinical niches or address specific procedural pain points, such as reducing procedural time or improving conformability in anatomically challenging defects. Strategic partnerships between device innovators, contract manufacturers, and regional distributors are common, providing scalability and localization advantages. Additionally, some companies emphasize digital integration-such as enhanced imaging compatibility and data capture tools-to support real-world evidence initiatives and facilitate post-market surveillance. Collectively, the competitive landscape rewards those who can marry technical performance with demonstrable outcomes and a clear plan for clinician support and market access.

Practical, high-impact actions industry leaders can implement to accelerate adoption and commercial success for PFO closure devices through aligned product, clinical, and go-to-market strategies

Industry leaders seeking to expand clinical adoption and commercial performance for PFO closure solutions should pursue a multi-dimensional strategy that aligns engineering, evidence generation, and go-to-market design. First, invest in product development that balances mechanical reliability with ease of deployment, prioritizing materials and delivery mechanisms that demonstrably reduce procedural variability and complication rates. Second, build a rigorous evidence-generation roadmap that includes prospective registries and pragmatic trials to validate outcomes across diverse practice settings, thereby addressing payer and hospital decision criteria. Third, design clinician education and proctoring programs that integrate simulation-based training and on-site support to shorten the learning curve and reinforce best practices.

Complementing clinical initiatives, refine distribution and pricing strategies to reflect the realities of ambulatory surgical centers versus hospital systems, and consider hybrid models that combine direct sales for key accounts with distributor partnerships to scale reach. Supply chain resilience should be addressed proactively through dual sourcing and selective regional manufacturing to mitigate tariff and trade risks while maintaining cost competitiveness. Finally, leverage digital tools to capture real-world performance and streamline post-market surveillance, creating a virtuous cycle of data that supports continuous product improvement and strengthens reimbursement narratives.

A rigorous, multi-source research methodology integrating clinician interviews, technical device assessments, regulatory review, and commercial channel analysis to ensure robust insights

This analysis synthesizes primary expert interviews, device technical specifications, regulatory documentation, clinical literature, and public policy signals to produce a holistic perspective on the PFO closure device landscape. Primary research included structured consultations with interventional cardiologists, electrophysiologists, hospital procurement leaders, and distribution partners to capture practical considerations around device selection, procedural workflows, and service expectations. Secondary inputs encompassed peer-reviewed clinical studies, device labeling and instructions for use, and publicly available regulatory decisions to ensure alignment between claimed device performance and real-world application.

Analytical frameworks focused on segment-level demand drivers, technology adoption curves, and commercial channel economics. Cross-validation steps involved triangulating clinician perspectives with technical device features and distribution strategies to highlight areas of alignment and tension. Wherever possible, assertions were grounded in multiple independent sources to ensure robustness. The methodology intentionally emphasized qualitative depth-capturing clinician workflow implications and hospital adoption barriers-while integrating quantitative indicators relating to procedural settings and device complexity to inform strategic recommendations.

A concise synthesis of the clinical, commercial, and regulatory imperatives that will determine which PFO closure solutions achieve durable adoption and value-based acceptance

In closing, the PFO closure device arena is characterized by converging forces: material and delivery innovation, pragmatic clinical evidence needs, and commercial models that must satisfy both high-volume hospital systems and expanding ambulatory care settings. Success for manufacturers and stakeholders will depend on the ability to deliver demonstrable clinical value, simplify procedural adoption, and align distribution and pricing strategies with diverse end-use settings. The interplay of tariffs, regional regulatory landscapes, and evolving payer expectations further underscores the need for adaptable supply chains and targeted market entry plans.

For clinicians and health-system leaders, the priority remains choosing devices and workflows that consistently deliver patient-centered outcomes while optimizing resource use. For commercial leaders, the imperative is to link technical differentiation with evidence generation and service models that de-risk adoption for hospitals and ambulatory centers. By integrating these perspectives into cohesive strategic plans, stakeholders can position products to meet both clinical imperatives and commercial realities in the evolving PFO closure landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PFO Closure Device Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Guidewire
    • 8.1.2. Sheath
    • 8.1.3. Stabilization Sleeve
  • 8.2. Delivery System
    • 8.2.1. Automated Delivery Mechanism
    • 8.2.2. Manual Delivery Mechanism
  • 8.3. Occluder
    • 8.3.1. Double Disc
    • 8.3.2. Single Disc

9. PFO Closure Device Market, by Procedure Type

  • 9.1. Surgical Closure
    • 9.1.1. Minimally Invasive
    • 9.1.2. Open Surgery
  • 9.2. Transcatheter Closure
    • 9.2.1. Femoral Vein Access
    • 9.2.2. Jugular Vein Access

10. PFO Closure Device Market, by Material Type

  • 10.1. Nitinol
  • 10.2. Polymer
    • 10.2.1. Dacron
    • 10.2.2. Eptfe

11. PFO Closure Device Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Pediatric

12. PFO Closure Device Market, by End Use

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. PFO Closure Device Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. PFO Closure Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. PFO Closure Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. PFO Closure Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States PFO Closure Device Market

18. China PFO Closure Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Artech Medical, Inc.
  • 19.7. BIOTRONIK SE & Co. KG
  • 19.8. Boston Scientific Corporation
  • 19.9. Cardia, Inc.
  • 19.10. Cardiovascular Systems, Inc.
  • 19.11. Coherex Medical, Inc.
  • 19.12. Lepu Medical Technology (Beijing) Co., Ltd.
  • 19.13. Lifetech Scientific (Shenzhen) Co., Ltd.
  • 19.14. Medtronic plc
  • 19.15. Meril Life Sciences Pvt. Ltd.
  • 19.16. MicroPort Scientific Corporation
  • 19.17. Neovasc Inc.
  • 19.18. Occlutech International AG
  • 19.19. pfm medical ag
  • 19.20. Sahajanand Medical Technologies Limited
  • 19.21. Starway Medical Technology, Inc.
  • 19.22. Surmodics, Inc.
  • 19.23. Vascular Innovations Co., Ltd.
  • 19.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PFO CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PFO CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PFO CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY GUIDEWIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY GUIDEWIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY GUIDEWIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SHEATH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SHEATH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SHEATH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY STABILIZATION SLEEVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY STABILIZATION SLEEVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY STABILIZATION SLEEVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY AUTOMATED DELIVERY MECHANISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY AUTOMATED DELIVERY MECHANISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY AUTOMATED DELIVERY MECHANISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY MANUAL DELIVERY MECHANISM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY MANUAL DELIVERY MECHANISM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY MANUAL DELIVERY MECHANISM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DOUBLE DISC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DOUBLE DISC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DOUBLE DISC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SINGLE DISC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SINGLE DISC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SINGLE DISC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY FEMORAL VEIN ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY FEMORAL VEIN ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY FEMORAL VEIN ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY JUGULAR VEIN ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY JUGULAR VEIN ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY JUGULAR VEIN ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DACRON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DACRON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DACRON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY EPTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY EPTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY EPTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. GCC PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. GCC PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. GCC PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 214. GCC PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 215. GCC PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 216. GCC PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. GCC PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. GCC PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 221. GCC PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. GCC PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. G7 PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. G7 PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 253. G7 PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 254. G7 PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 255. G7 PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 257. G7 PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. G7 PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 260. G7 PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. G7 PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 262. G7 PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. NATO PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. NATO PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 266. NATO PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 267. NATO PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 268. NATO PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 270. NATO PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 271. NATO PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. NATO PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 273. NATO PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 274. NATO PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL PFO CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA PFO CLOSURE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY OCCLUDER, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY SURGICAL CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY TRANSCATHETER CLOSURE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA PFO CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)